To target E2 to -cells without the undesirable effects of general estrogen therapy, we created fusion peptides combining active or inactive glucagon-like peptide-1 (GLP-1) and E2 in a single molecule (aGLP1-E2 and iGLP1-E2 respectively)
However, mood symptoms may return if weight is regained, if previous coping patterns reemerge, or if individuals find that weight loss alone does not resolve underlying issues related to relationships, self-esteem, or other psychosocial concerns
We can help you establish your lipotropic program
Your provider will determine whether labs are required based on your health history and goals
If your pharmacy provides it in lyophilized (freeze-dried) form requiring reconstitution, the process follows standard peptide reconstitution protocols
Side-effect burden: overlapping nausea or low intake can become hard to interpret